Most COVID-19 antibody treatments given in assisted living, analysts find
By
Alicia Lasek
Feb 22, 2021
Fully 67% of monoclonal antibody treatments have been administered in assisted living communities. Health officials would like to encourage greater use.
Antibody drug cut COVID-19 risk by up to 80% in residents, study finds
By
Danielle Brown
Jan 22, 2021
A COVID-19 antibody therapy was able to drastically reduce the risk of nursing home residents contracting COVID-19, according to new study results released Thursday by drugmaker Eli Lilly.
New ‘weapon in our arsenal’: Antibody drug cuts COVID risk by 80 percent in LTC residents
By
Alicia Lasek
Jan 22, 2021
Staff and residents who received Eli Lilly’s monoclonal antibody therapy were less likely to contract symptomatic COVID-19 than placebo groups in a late-stage trial. Industry advocates are hailing...
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Dosing discrepancy for Eli Lilly’s new COVID therapy begets clinician confusion
By
Alicia Lasek
Nov 12, 2020
Some clinicians are questioning the decision to authorize 700 mg doses of the intravenous drug rather than a higher dose that was effective in clinical trials. But Eli Lilly and federal health officials...
Feds race to buy COVID antibody cocktails
By
Alicia Lasek
Oct 14, 2020
The federal government is planning to stockpile COVID-19 antibody drugs in an effort to ensure treatment availability while the country awaits a vaccine.
Two groundbreaking diabetes drugs endorsed by EU regulators
By
Alicia Lasek
Feb 02, 2020
A fast-acting version of Liumjev (insulin lispro), and an oral (non-injectable) version of semaglutide have been recommended for approval.
Clinical Briefs for Wednesday, January 15
By
Alicia Lasek
Jan 14, 2020
‘Ageotypes’ study ties healthy behaviors to decrease in aging markers … Access to Medicare increases cancer detection, reduces cancer mortality rate … Psychiatric conditions linked to cognitive...
Pharma companies embrace branding
By
Elizabeth Newman
Mar 01, 2014
Big pharmaceutical companies are exploring “brand personality” in their marketing strategies, according to new research.
Diabetes—obesity drug to be created
By
Elizabeth Newman
Oct 01, 2013
U.S. pharmacy giant Eli Lilly and Company and Denmark’s Zealand Pharma are working on new treatments for type 2 diabetes and obesity, the companies announced.